<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Clinical manifestations of hypocalcemia</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Clinical manifestations of hypocalcemia</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Clinical manifestations of hypocalcemia</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David Goltzman, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Clifford J Rosen, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jean E Mulder, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 02, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Hypocalcemia may be associated with a spectrum of clinical manifestations (<a class="graphic graphic_table graphicRef62347" href="/z/d/graphic/62347.html" rel="external">table 1</a>), ranging from few (if any) symptoms if the hypocalcemia is mild to life-threatening seizures, refractory heart failure, or laryngospasm if it is severe. In addition to severity, the rate of development of hypocalcemia and chronicity determine the clinical manifestations.</p><p>Among the symptoms of hypocalcemia, tetany, papilledema, and seizures may occur in patients who develop hypocalcemia acutely. By comparison, ectodermal and dental changes, cataracts, basal ganglia calcification, and extrapyramidal disorders are features of chronic hypocalcemia. These last findings are most common in patients with hypoparathyroidism.</p><p>The clinical manifestations of hypocalcemia are discussed here. The etiology of, diagnostic approach to, and treatment of hypocalcemia are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/840.html" rel="external">"Etiology of hypocalcemia in adults"</a> and  <a class="medical medical_review" href="/z/d/html/837.html" rel="external">"Diagnostic approach to hypocalcemia"</a> and  <a class="medical medical_review" href="/z/d/html/826.html" rel="external">"Treatment of hypocalcemia"</a> and  <a class="medical medical_review" href="/z/d/html/99737.html" rel="external">"Hypoparathyroidism"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">ACUTE MANIFESTATIONS</span><span class="headingEndMark"> — </span>The hallmark of acute hypocalcemia is tetany, which is characterized by neuromuscular irritability. As measured electromyographically, tetany consists of repetitive, high-frequency discharges after a single stimulus. Hyperexcitability of peripheral neurons is probably the most important pathophysiologic effect of hypocalcemia, but hyperexcitability occurs at all levels of the nervous system, including motor endplates, the spinal reflexes, and the central nervous system.</p><p class="headingAnchor" id="H3"><span class="h2">Tetany</span><span class="headingEndMark"> — </span>Acute hypocalcemia directly increases peripheral neuromuscular irritability [<a href="#rid1">1</a>]. The symptoms of tetany may be mild (perioral numbness, paresthesias of the hands and feet, muscle cramps) or severe (carpopedal spasm, laryngospasm, and focal or generalized seizures, which must be distinguished from the generalized tonic muscle contractions that occur in severe tetany) (<a class="graphic graphic_table graphicRef62347" href="/z/d/graphic/62347.html" rel="external">table 1</a>) [<a href="#rid2">2</a>]. Other patients have less specific symptoms (such as fatigue, hyperirritability, anxiety, and depression), and some patients, even with severe hypocalcemia, have no neuromuscular symptoms.</p><p>The classic physical findings in patients with neuromuscular irritability due to latent tetany are Trousseau's and Chvostek's signs. (See <a class="local">'Trousseau's sign'</a> below and <a class="local">'Chvostek's sign'</a> below.)</p><p>Tetany is uncommon unless the serum ionized calcium concentration falls below 4.3 mg/dL (1.1 mmol/L), which usually corresponds to a serum total calcium concentration of 7.0 to 7.5 mg/dL (1.8 to 1.9 mmol/L). Patients in whom the onset of hypocalcemia is gradual tend to have fewer symptoms at the same serum calcium concentration [<a href="#rid2">2</a>].</p><p>Other factors that determine the variation in frequency and severity of symptoms include acid-base status, hypomagnesemia, and potassium balance [<a href="#rid3">3,4</a>]. (See  <a class="medical medical_review" href="/z/d/html/848.html" rel="external">"Hypomagnesemia: Clinical manifestations of magnesium depletion", section on 'Calcium metabolism'</a>.)</p><p>Hypocalcemia and alkalosis act synergistically to cause tetany. Although alkalosis can directly reduce serum ionized calcium, the ability of alkalosis to enhance tetany is only partly due to this effect since the decrease is relatively small. Respiratory alkalosis alone (eg, hyperventilation) can cause tetany, even in the absence of underlying hypocalcemia. By contrast, tetany is unusual among patients with chronic renal failure and hypocalcemia (occasionally severe) because of the protective effect of concurrent metabolic acidosis.</p><p class="headingAnchor" id="H4"><span class="h3">Trousseau's sign</span><span class="headingEndMark"> — </span>Trousseau's sign is the induction of carpal spasm by inflation of a sphygmomanometer above systolic blood pressure for three minutes [<a href="#rid5">5,6</a>]. Carpal spasm is characterized by adduction of the thumb, flexion of the metacarpophalangeal joints, extension of the interphalangeal joints, and flexion of the wrist (<a class="graphic graphic_figure graphicRef112757" href="/z/d/graphic/112757.html" rel="external">figure 1</a>). It may also be induced by voluntary hyperventilation for one to two minutes after release of the cuff. </p><p>Trousseau's sign depends upon the effect of ischemia to increase excitability of the nerve trunk under the cuff, rather than at the motor endplate; excitability is maximal at three minutes and returns to normal even if ischemia is maintained for a longer period.</p><p class="headingAnchor" id="H5"><span class="h3">Chvostek's sign</span><span class="headingEndMark"> — </span>Chvostek's sign is contraction of the ipsilateral facial muscles elicited by tapping the facial nerve just anterior to the ear [<a href="#rid5">5</a>]. The response ranges from twitching of the lip to spasm of all facial muscles and depends upon the severity of the hypocalcemia (<a class="graphic graphic_figure graphicRef112758" href="/z/d/graphic/112758.html" rel="external">figure 2</a>). Chvostek's sign occurs in approximately 10 percent of normal subjects [<a href="#rid5">5,6</a>].</p><p>Although Trousseau's sign is more specific than Chvostek's sign, both may be negative in patients with hypocalcemia [<a href="#rid5">5</a>].</p><p class="headingAnchor" id="H6"><span class="h2">Seizures</span><span class="headingEndMark"> — </span>Generalized tonic-clonic, generalized absence, and focal seizures can occur in hypocalcemia and may be the sole presenting symptom [<a href="#rid7">7,8</a>] . The presence of seizures without tetany in patients with hypocalcemia may be explained by the observation that low cerebrospinal fluid ionized calcium concentrations may have a convulsive [<a href="#rid9">9</a>] but not a direct tetanic effect. In patients with seizures caused by hypocalcemia, the electroencephalogram (EEG) shows both spikes ("convulsive effect") and bursts of high-voltage, paroxysmal slow waves [<a href="#rid10">10</a>].</p><p class="headingAnchor" id="H7"><span class="h2">Cardiovascular</span><span class="headingEndMark"> — </span>Hypotension may complicate acute hypocalcemia, particularly when rapidly induced by ethylenediaminetetraacetic acid (EDTA), transfusion of citrated blood, or with use of low calcium dialysate in patients undergoing renal replacement therapy [<a href="#rid11">11-14</a>]. In addition, decreased myocardial performance and even congestive heart failure (with or without hypotension) have been reported [<a href="#rid15">15-20</a>]. Myocardial dysfunction is reversible with calcium repletion [<a href="#rid18">18,21</a>]. Although the mechanism is undefined, calcium plays a critical role in excitation-contraction coupling and is required for epinephrine-induced glycogenolysis in the heart. (See  <a class="medical medical_review" href="/z/d/html/3451.html" rel="external">"Excitation-contraction coupling in myocardium"</a>.)</p><p>Hypocalcemia characteristically causes prolongation of the QT interval in the electrocardiogram (<a class="graphic graphic_waveform graphicRef66206" href="/z/d/graphic/66206.html" rel="external">waveform 1</a>) [<a href="#rid22">22,23</a>]. Hypocalcemia prolongs phase 2 of the action potential with the impact modulated by the rate of change of serum calcium concentration and function of the myocyte calcium channels. Prolongation of the QT interval is associated with early after-depolarizations and triggered dysrhythmias. Torsades de pointes (polymorphic ventricular tachycardia associated with a prolonged QT interval) can potentially be triggered by hypocalcemia but is much less common than with hypokalemia or hypomagnesemia. Although electrocardiographic conduction abnormalities are common, serious hypocalcemia-induced dysrhythmias, such as heart block and ventricular dysrhythmias, are infrequent.</p><p class="headingAnchor" id="H8"><span class="h2">Papilledema</span><span class="headingEndMark"> — </span>Papilledema can occur in patients with hypocalcemia of any cause [<a href="#rid24">24-26</a>]. It occurs only when hypocalcemia is severe, and it usually improves with reversal of hypocalcemia. It may or may not be accompanied by high cerebrospinal fluid pressure (benign intracranial hypertension). Rarely, optic neuritis (distinguished by decreased visual acuity) rather than papilledema is present [<a href="#rid24">24</a>].</p><p class="headingAnchor" id="H9"><span class="h2">Psychiatric manifestations</span><span class="headingEndMark"> — </span>Hypocalcemia can cause psychological symptoms, particularly emotional instability, anxiety, and depression. Less common are confusional states, hallucinations, and frank psychosis. All are reversible with treatment [<a href="#rid27">27</a>].</p><p class="headingAnchor" id="H10"><span class="h1">DISEASE-SPECIFIC MANIFESTATIONS</span></p><p class="headingAnchor" id="H11"><span class="h2">Hypoparathyroidism</span><span class="headingEndMark"> — </span>Although the signs and symptoms of acute hypocalcemia are similar regardless of the etiology, there are several clinical manifestations that are unique to chronic hypoparathyroidism. These include basal ganglia calcifications, cataracts, dental abnormalities, and ectodermal manifestations (<a class="graphic graphic_table graphicRef62347" href="/z/d/graphic/62347.html" rel="external">table 1</a>). These clinical features are reviewed in more detail separately. (See  <a class="medical medical_review" href="/z/d/html/99737.html" rel="external">"Hypoparathyroidism", section on 'Chronic manifestations'</a>.)</p><p class="headingAnchor" id="H17"><span class="h2">Pseudohypoparathyroidism</span><span class="headingEndMark"> — </span>Pseudohypoparathyroidism (PHP) refers to a group of heterogeneous disorders defined by renal unresponsiveness to parathyroid hormone (PTH) and characterized biochemically by hypocalcemia, hyperphosphatemia, and elevated PTH concentrations. There are several subtypes of PHP, based upon genetic and clinical characteristics [<a href="#rid28">28</a>]. Some variants of PHP are associated with skeletal abnormalities, intellectual impairment, and resistance to other hormones. PHP is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/5846.html" rel="external">"Etiology of hypocalcemia in infants and children", section on 'End-organ resistance to PTH (pseudohypoparathyroidism)'</a>.)</p><p class="headingAnchor" id="H18"><span class="h2">Vitamin D deficiency</span><span class="headingEndMark"> — </span>Vitamin D deficiency or resistance can cause hypocalcemia and, if severe, lead to rickets and osteomalacia. In addition to the classic radiographic signs of vitamin D deficiency rickets, children may have muscle weakness and hypotonia, motor retardation, and stunted growth. Children with vitamin D receptor mutations may also have alopecia, multiple milia, epidermal cysts, and oligodontia. (See  <a class="medical medical_review" href="/z/d/html/2048.html" rel="external">"Causes of vitamin D deficiency and resistance", section on 'Vitamin D resistance'</a> and  <a class="medical medical_review" href="/z/d/html/5856.html" rel="external">"Overview of rickets in children", section on 'Clinical manifestations'</a>.)</p><p>Osteomalacia may be asymptomatic and present radiologically as osteopenia. It can also produce characteristic symptoms including diffuse bone pain and tenderness and muscle weakness. (See  <a class="medical medical_review" href="/z/d/html/2040.html" rel="external">"Clinical manifestations, diagnosis, and treatment of osteomalacia in adults", section on 'Clinical features'</a>.)</p><p class="headingAnchor" id="H1216226"><span class="h2">Autosomal dominant hypocalcemia</span><span class="headingEndMark"> — </span>Autosomal dominant hypocalcemia (ADH) is caused by an activating mutation of the calcium-sensing receptor (<em>CaSR</em>) gene (ADH type 1) or by gain-of-function mutations of G-alpha-11, a key mediator of CASR signaling (ADH type 2) [<a href="#rid29">29</a>]. In ADH1 and ADH2, there is a downward resetting of the PTH-calcium relationship, such that PTH is not released at serum calcium concentrations that normally trigger PTH release, thereby causing hypocalcemia with low or inappropriately normal PTH levels. The majority of patients with ADH are asymptomatic and, therefore, are not diagnosed until adulthood, when hypocalcemia is incidentally noted. A few patients, however, have symptomatic hypocalcemia. The major clinical clue to this syndrome is its familial nature and the tendency of patients to develop renal complications during treatment with calcium and vitamin D supplementation. </p><p>Some patients also have potassium wasting, hypokalemia, and metabolic alkalosis, creating a phenotype similar to Bartter syndrome. (See  <a class="medical medical_review" href="/z/d/html/838.html" rel="external">"Disorders of the calcium-sensing receptor: Familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia", section on 'Autosomal dominant hypocalcemia'</a>.)</p><p class="headingAnchor" id="H30029206"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/17220.html" rel="external">"Patient education: Hypoparathyroidism (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H19"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – The clinical manifestations of hypocalcemia depend upon the severity and chronicity of hypocalcemia (<a class="graphic graphic_table graphicRef62347" href="/z/d/graphic/62347.html" rel="external">table 1</a>). (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acute hypocalcemia</strong> – The signs and symptoms of acute hypocalcemia are similar regardless of the etiology. The hallmark of acute hypocalcemia is tetany, which is characterized by neuromuscular irritability. Symptoms range from mild paresthesias to carpopedal spasm to seizures (<a class="graphic graphic_figure graphicRef112757" href="/z/d/graphic/112757.html" rel="external">figure 1</a> and <a class="graphic graphic_figure graphicRef112758" href="/z/d/graphic/112758.html" rel="external">figure 2</a>). (See <a class="local">'Acute manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Disease-specific manifestations</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Hypoparathyroidism</strong> – Chronic hypocalcemia from hypoparathyroidism may be associated with cataract formation, ectopic calcification (basal ganglia), and occasionally parkinsonism and dementia. (See  <a class="medical medical_review" href="/z/d/html/99737.html" rel="external">"Hypoparathyroidism", section on 'Clinical features'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Pseudohypoparathyroidism</strong> – Pseudohypoparathyroidism (PHP) refers to a group of heterogeneous disorders defined by renal unresponsiveness to parathyroid hormone (PTH) and characterized biochemically by hypocalcemia and hyperphosphatemia with elevated PTH concentrations. Some variants of PHP are associated with skeletal abnormalities, intellectual impairment, and resistance to other hormones. (See  <a class="medical medical_review" href="/z/d/html/5846.html" rel="external">"Etiology of hypocalcemia in infants and children", section on 'End-organ resistance to PTH (pseudohypoparathyroidism)'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Vitamin D deficiency or resistance</strong> – Vitamin D deficiency or resistance can cause hypocalcemia and, if severe, rickets and osteomalacia. In addition to the classic radiographic signs of vitamin D deficiency rickets, children with rickets may have muscle weakness and hypotonia, motor retardation, and stunted growth. Osteomalacia may be asymptomatic and present radiologically as osteopenia. It can also produce characteristic symptoms including diffuse bone pain and tenderness and muscle weakness. (See  <a class="medical medical_review" href="/z/d/html/5856.html" rel="external">"Overview of rickets in children", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/z/d/html/2040.html" rel="external">"Clinical manifestations, diagnosis, and treatment of osteomalacia in adults", section on 'Clinical features'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Autosomal dominant hypocalcemia</strong> – Autosomal dominant hypocalcemia (ADH) is caused by an activating mutation of the calcium-sensing receptor (<em>CaSR</em>) gene or a gain-of-function mutation in an important molecule in the CASR signaling pathway. The majority of patients with ADH are asymptomatic and, therefore, are not diagnosed until adulthood, when hypocalcemia is incidentally noted. (See  <a class="medical medical_review" href="/z/d/html/838.html" rel="external">"Disorders of the calcium-sensing receptor: Familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia", section on 'Autosomal dominant hypocalcemia'</a>.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Macefield G, Burke D. Paraesthesiae and tetany induced by voluntary hyperventilation. Increased excitability of human cutaneous and motor axons. Brain 1991; 114 ( Pt 1B):527.</a></li><li><a class="nounderline abstract_t">Bilezikian JP. Hypoparathyroidism. J Clin Endocrinol Metab 2020; 105:1722.</a></li><li><a class="nounderline abstract_t">Navarro J, Oster JR, Gkonos PJ, et al. Tetany induced on separate occasions by administration of potassium and magnesium in a patient with hungry-bone syndrome. Miner Electrolyte Metab 1991; 17:340.</a></li><li><a class="nounderline abstract_t">Cohen L. Potassium replacement associated with the development of tetany in a patient with hypomagnesaemia. Magnes Res 1993; 6:43.</a></li><li><a class="nounderline abstract_t">Cooper MS, Gittoes NJ. Diagnosis and management of hypocalcaemia. BMJ 2008; 336:1298.</a></li><li class="breakAll">Thakker RV. Hypocalcemia: Pathogenesis, differential diagnosis, and management. In: Primer on the metabolic bone diseases and disorders of mineral metabolism, 6th ed, Favus MJ (Ed), American Society of Bone and Mineral Research, Washington, DC 2006. p.213.</li><li><a class="nounderline abstract_t">Armelisasso C, Vaccario ML, Pontecorvi A, Mazza S. Tonic-clonic seizures in a patient with primary hypoparathyroidism: a case report. Clin EEG Neurosci 2004; 35:97.</a></li><li><a class="nounderline abstract_t">Mrowka M, Knake S, Klinge H, et al. Hypocalcemic generalised seizures as a manifestation of iatrogenic hypoparathyroidism months to years after thyroid surgery. Epileptic Disord 2004; 6:85.</a></li><li><a class="nounderline abstract_t">Zuckermann EC, Glaser GH. Anticonvulsive action of increased calcium concentration in cerebrospinal fluid. Arch Neurol 1973; 29:245.</a></li><li><a class="nounderline abstract_t">Swash M, Rowan AJ. Electroencephalographic criteria of hypocalcemia and hypercalcemia. Arch Neurol 1972; 26:218.</a></li><li><a class="nounderline abstract_t">Denlinger JK, Nahrwold ML. Cardiac failure associated with hypocalcemia. Anesth Analg 1976; 55:34.</a></li><li><a class="nounderline abstract_t">Ghent S, Judson MA, Rosansky SJ. Refractory hypotension associated with hypocalcemia and renal disease. Am J Kidney Dis 1994; 23:430.</a></li><li><a class="nounderline abstract_t">Brunelli SM, Sibbel S, Do TP, et al. Facility Dialysate Calcium Practices and Clinical Outcomes Among Patients Receiving Hemodialysis: A Retrospective Observational Study. Am J Kidney Dis 2015; 66:655.</a></li><li><a class="nounderline abstract_t">Thurlow JS, Yuan CM. Dialysate-induced hypocalcemia presenting as acute intradialytic hypotension: A case report, safety review, and recommendations. Hemodial Int 2016; 20:E8.</a></li><li><a class="nounderline abstract_t">Shinoda T, Aizawa T, Shirota T, et al. Exacerbation of latent heart failure by mild hypocalcemia after parathyroidectomy in a long-term hemodialysis patient. Nephron 1992; 60:482.</a></li><li><a class="nounderline abstract_t">Kazmi AS, Wall BM. Reversible congestive heart failure related to profound hypocalcemia secondary to hypoparathyroidism. Am J Med Sci 2007; 333:226.</a></li><li><a class="nounderline abstract_t">Levine SN, Rheams CN. Hypocalcemic heart failure. Am J Med 1985; 78:1033.</a></li><li><a class="nounderline abstract_t">Wong CK, Lau CP, Cheng CH, et al. Hypocalcemic myocardial dysfunction: short- and long-term improvement with calcium replacement. Am Heart J 1990; 120:381.</a></li><li><a class="nounderline abstract_t">Kudoh C, Tanaka S, Marusaki S, et al. Hypocalcemic cardiomyopathy in a patient with idiopathic hypoparathyroidism. Intern Med 1992; 31:561.</a></li><li><a class="nounderline abstract_t">Brunvand L, Hågå P, Tangsrud SE, Haug E. Congestive heart failure caused by vitamin D deficiency? Acta Paediatr 1995; 84:106.</a></li><li><a class="nounderline abstract_t">Rimailho A, Bouchard P, Schaison G, et al. Improvement of hypocalcemic cardiomyopathy by correction of serum calcium level. Am Heart J 1985; 109:611.</a></li><li><a class="nounderline abstract_t">Benoit SR, Mendelsohn AB, Nourjah P, et al. Risk factors for prolonged QTc among US adults: Third National Health and Nutrition Examination Survey. Eur J Cardiovasc Prev Rehabil 2005; 12:363.</a></li><li><a class="nounderline abstract_t">Meyer T, Ruppert V, Karatolios K, Maisch B. Hereditary long QT syndrome due to autoimmune hypoparathyroidism in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. J Electrocardiol 2007; 40:504.</a></li><li><a class="nounderline abstract_t">Bajandas FJ, Smith JL. Optic nueritis in hypoparathyroidism. Neurology 1976; 26:451.</a></li><li><a class="nounderline abstract_t">Sheldon RS, Becker WJ, Hanley DA, Culver RL. Hypoparathyroidism and pseudotumor cerebri: an infrequent clinical association. Can J Neurol Sci 1987; 14:622.</a></li><li><a class="nounderline abstract_t">Hochman HI, Mejlszenkier JD. Cataracts and pseudotumor cerebri in an infant with vitamin D-deficiency rickets. J Pediatr 1977; 90:252.</a></li><li><a class="nounderline abstract_t">Lin KF, Chen KH, Huang WL. Organic anxiety in a woman with breast cancer receiving denosumab. Gen Hosp Psychiatry 2015; 37:192.e7.</a></li><li><a class="nounderline abstract_t">Tafaj O, Jüppner H. Pseudohypoparathyroidism: one gene, several syndromes. J Endocrinol Invest 2017; 40:347.</a></li><li><a class="nounderline abstract_t">Roszko KL, Bi RD, Mannstadt M. Autosomal Dominant Hypocalcemia (Hypoparathyroidism) Types 1 and 2. Front Physiol 2016; 7:458.</a></li></ol></div><div id="topicVersionRevision">Topic 833 Version 20.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2004255" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Paraesthesiae and tetany induced by voluntary hyperventilation. Increased excitability of human cutaneous and motor axons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32322899" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Hypoparathyroidism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1819767" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Tetany induced on separate occasions by administration of potassium and magnesium in a patient with hungry-bone syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8369199" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Potassium replacement associated with the development of tetany in a patient with hypomagnesaemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18535072" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Diagnosis and management of hypocalcaemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18535072" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Diagnosis and management of hypocalcaemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15164818" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Tonic-clonic seizures in a patient with primary hypoparathyroidism: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15246952" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Hypocalcemic generalised seizures as a manifestation of iatrogenic hypoparathyroidism months to years after thyroid surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4728184" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Anticonvulsive action of increased calcium concentration in cerebrospinal fluid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4536776" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Electroencephalographic criteria of hypocalcemia and hypercalcemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/942827" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Cardiac failure associated with hypocalcemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8128946" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Refractory hypotension associated with hypocalcemia and renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26015274" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Facility Dialysate Calcium Practices and Clinical Outcomes Among Patients Receiving Hemodialysis: A Retrospective Observational Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26923551" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Dialysate-induced hypocalcemia presenting as acute intradialytic hypotension: A case report, safety review, and recommendations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1584326" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Exacerbation of latent heart failure by mild hypocalcemia after parathyroidectomy in a long-term hemodialysis patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17435416" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Reversible congestive heart failure related to profound hypocalcemia secondary to hypoparathyroidism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4014262" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Hypocalcemic heart failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2382615" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Hypocalcemic myocardial dysfunction: short- and long-term improvement with calcium replacement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1633370" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Hypocalcemic cardiomyopathy in a patient with idiopathic hypoparathyroidism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7734890" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Congestive heart failure caused by vitamin D deficiency?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2983522" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Improvement of hypocalcemic cardiomyopathy by correction of serum calcium level.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16079644" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Risk factors for prolonged QTc among US adults: Third National Health and Nutrition Examination Survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17289071" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Hereditary long QT syndrome due to autoimmune hypoparathyroidism in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/944396" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Optic nueritis in hypoparathyroidism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3690435" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Hypoparathyroidism and pseudotumor cerebri: an infrequent clinical association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/299772" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Cataracts and pseudotumor cerebri in an infant with vitamin D-deficiency rickets.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25772947" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Organic anxiety in a woman with breast cancer receiving denosumab.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27995443" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Pseudohypoparathyroidism: one gene, several syndromes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27803672" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Autosomal Dominant Hypocalcemia (Hypoparathyroidism) Types 1 and 2.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
